国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
同步放化疗与序贯放化疗治疗局部晚期非小细胞肺癌的疗效比较
Curative Effect Comparison of Concurrent Radiochemotherapy and Sequential Chemoradiotherapy in the Treatment of Locally Advanced Non small Cell Lung Cancer
  
DOI:
中文关键词:  同步放化疗  序贯疗法  非小细胞肺癌  药品不良反应
英文关键词:Synchronous radiotherapy and chemotherapy  Sequential therapy  Non small cell lung cancer  Adverse drug reactions
基金项目:
作者单位
胡春秀 浙江衢化医院肿瘤综合治疗中心放疗科(浙江衢州 324004) 
姜忠于 浙江衢化医院肿瘤综合治疗中心放疗科 
丁淑波 浙江大学金华中心医院 
郑勇明 浙江衢化医院肿瘤综合治疗中心放疗科 
王立 浙江衢化医院肿瘤综合治疗中心放疗科 
摘要点击次数: 1557
全文下载次数: 1422
中文摘要:
      摘 要 目的:比较同步放化疗与序贯放化疗治疗局部晚期非小细胞肺癌(NSCLC)的疗效和安全性。方法:268例局部晚期NSCLC患者随机分为同步组和序贯组,同步组采用多西他赛+顺铂化疗,并化疗第1天开始同步采用三维适形或调强放疗,同步2周期。序贯组采用多西他赛+顺铂化疗2周期后,采用三维适形或调强放疗,放疗结束后两组均再化疗2个周期。比较两组的近期疗效、生活质量和药品不良反应。结果:同步组总缓解率为73.13%,序贯组为50.75%,两组差异有统计学意义(P<0.05)。同步组生活质量提高率为22.39%,明显高于序贯组的11.94%(P<0.05)。两组Ⅲ~Ⅳ级放射性肺炎、Ⅲ~Ⅳ级放射性食管炎、Ⅲ~Ⅳ级骨髓抑制和Ⅲ~Ⅳ级胃肠道反应发生率比较,差异均无统计学意义(P>0.05)。结论:同步放化疗能明显增强局部晚期NSCLC的治疗效果,提高生活质量,并未明显增加不良反应风险。
英文摘要:
      ABSTRACT Objective: To compare the curative effect and adverse drug reaction of concurrent chemotherapy and sequential chemoradiotherapy for locally advanced non smallcell lung cancer(NSCLC). Methods:268 patients with locally advanced NSCLC were divided randomly into synchronous groupand sequential group. Synchronous group treated with docetaxel +DDP chemotherapy and combined with concurrent radiotherapy for first day beginning, 2 cycle synchronization. Sequential group treated with docetaxel +DDP chemotherapy, after two cycles three dimensional conformal or intensity modulated radiation therapy was used. After the end of radiotherapy were chemotherapy 2 cycle again in two groups.The short termefficacy, life quality and adverse drug reaction of two groups were compared. Results:The total alleviation rates of two groups was 73.13% and 50.75%, differences were statistically significant (P<0.05).The increasing rate of life quality of synchronous group was 22.39%, which was significantly higher than the 11.94% of sequential group (P<0.05). Adverse drug reactions, including the level 3-4 radioactive pneumonia, the level 3 4 radioactive esophagitis, level 3-4 the digestive tract reaction, and the level 3 4 bone marrowsuppression of two groups, there were no statistically significant difference (P>0.05). Conclusion:The concurrent chemotherapy can significantly enhance the curative effect to the locally advanced NSCLC, improve life quality, but it was not obvious to increased adverse drug reactions.
查看全文  查看/发表评论  下载PDF阅读器
关闭